speakers

speaker list | presenting companies

The ChinaBio® Investor Forum features speakers from the US and China that are renowned experts in their fields, including:

• The State of the China Biotech Industry - China's biotech and life science industry is rapidly becoming a global force.  And it is the fastest growing industry segment in VC investment.
• Attacting Capital - Learn what US and China investors are looking for in early and mid-stage biotechnology, diagnostics and services companies, and hear entrepreneurs tell their success stories.
• Challenges and Legal Issues - Many challenges face the entrepreneur and investor including China's new labor laws and investment policies, the Foreign Corrupt Practices Act, IP transfer limitations, corporate structure, etc.
• Partnering in China - How to reduce your costs and improve the return on investment by partnering with major pharma or using CROs and CMOs in China to perform much of the work in drug development. 

Speaker List

The following industry experts will be providing insights into China's emerging biotechnology industry and how to launch and build a successful life science companies at the ChinaBio® Investor Forum.  (Click here for Speaker Bios.)

Keynote Speakers:

William Keller – Vice GM / Chairman, SH Z.J. Biotech & Pharmaceutical Base Development Co., Ltd / HBM BioMed China

Jason Jin, PhD - President, ShanghaiBio Corporation

Greg B. Scott – President and founder, ChinaBio Accelerator

Speakers and Panelists:

Charles Hsu, PhD, MBA - Partner, Bay City Capital
Jennifer Hu, PhD - Director of Licensing & External Research, Merck & Co.
Kevin Li, PhD - Partner, HBM BioMed China
Wayne Li, PhD – General Project Manager, Morningside
Huang Lu, MD, MBA – Director, Morningside
D. Thomas Oakley, MBA, CEO – Bridge Laboratories
R. Stephen Porter, PhD – CSO, Medicilon-MPI Preclinical Research Shanghai
Yi Shi, PhD – Managing Director, Lilly Asian Ventures
Tai-Sen Soong, PhD – President, CDIB Bioscience Venture Management
Xuehai Tan, PhD – CEO/President, HD Bio Co., Ltd
Kevin Xie - Partner, China Renaissance Partners
David Xu, PhD - Managing Partner, Mingly China Growth Fund
Michael Xu, MD, PhD – CEO, PegBio Co., Ltd
Stella Xu, PhD - Licensing Director, Roche Pharma
Chika Yoshinaga, MD – Vice President of Asia, Sofinnova Partners
Ningni Yu, MD - Vice President, Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Co., China
Joe Zhang, PhD – Vice President China Operations, CHI
Wei Zhou, PhD, JD – Partner, WSGR
Carol Zhu, MBA – Head of Operations and Alliances, GSK R&D China
James Zhu, PhD, JD – Partner, Perkins Coie LLP
Kan Zu, LLM – Partner, Unitalen Attorneys at Law

Presenting Companies

The following companies have been selected bywill be presenting at the ChinaBio® Investor Forum:

Click here to register...